IVF clinic CPL reduction case study: how an ICG IVF client in Delhi with two centres dropped CPL from ₹1,890 to ₹732 in 90 days using Meta Catalyst IQ

This is a case study of a real 90-day CPL reduction on an anonymised ICG IVF client — a mid-sized fertility practice in Delhi with two centres serving South Delhi and Gurgaon catchments, running roughly ₹4.8L per month in Meta ads spend before ICG engagement began. Starting CPL was ₹1,890 blended across both centres, well above the ICG IVF portfolio benchmark of ₹632. The 90-day intervention followed the standard Meta Catalyst IQ diagnostic sequence — Hygiene Factors, Naming Intelligence, Creative Scoring Matrix, Money Wastage Cleanup, CPQL Engine — and ended with a CPL of ₹732 by day 90, which sits inside the ICG portfolio benchmark range though slightly above the ₹632 blended average. This post walks through what happened week by week, what worked, what did not work as fast as expected, and what the honest limits of a 90-day intervention actually look like on an IVF account.

The starting picture, day zero

The intake audit revealed a set of issues that would look familiar to any experienced IVF media buyer. The Meta ad account had 34 active ad sets across the two centres, with a findability score of 41 percent — 20 ad sets did not conform to any consistent naming schema. Beacon (ICG's Meta CAPI attribution engine) was not installed, meaning roughly 35 to 45 percent of the qualified-lead attribution signal was being lost to iOS14 and third-party cookie deprecation. The Hygiene Factors 12-point checklist failed on 4 checks — one broken purchase event on the second centre's pixel, an unsynced Custom Audience that had not refreshed in 90+ days, an expired Lookalike, and inconsistent frequency capping across ad sets.

Creative Scoring on the existing 61 active ads showed a wide spread — 8 ads in Core Performer, 12 in Scalable, 19 in Getting Started, and 22 in Review. Money Wastage was estimated at ₹1.42L per month based on the platform's initial pass. Audience Size vs Efficiency was inconclusive because the naming conflicts made per-audience-tier rollup unreliable.

The client's previous agency had reported the ₹1,890 CPL as normal for competitive IVF markets. What the audit clarified was that ₹1,890 was normal only for accounts without a diagnostic layer running underneath execution — accounts that ran the diagnostic layer consistently sat in the ₹650 to ₹950 range for the same competitive market conditions.

Weeks 1 and 2 — Hygiene Factors and Naming Intelligence

Week 1 was almost entirely hygiene. Beacon got installed on day 3, calibrated on day 5, and started producing meaningful CAPI signal by day 7. The four failing Hygiene checks got resolved by day 8. The pixel purchase event on the second centre was fixed on day 4 (a broken URL parameter that had been failing silently for approximately 11 weeks). The Custom Audience and Lookalike issues got fixed on day 6 and 7 respectively.

Week 2 was naming remediation. Naming Intelligence had flagged 14 ad sets for rename. The media buyer executed the renames in three batches over four low-delivery early-morning windows to avoid triggering Learning Phase resets. The findability score rose from 41 percent to 79 percent by day 14. Two ad sets required additional attention because renaming triggered an unintended audience recalibration that took 4 to 6 days to stabilise.

CPL movement in weeks 1 and 2 was modest — ₹1,890 declined to ₹1,720, a 9 percent improvement mostly attributable to the pixel fix (which restored proper attribution to purchase events that had been happening but not being counted). The Beacon-recovered attribution signal added back roughly 22 percent of previously-lost qualified-lead attribution, so the reported CPL improvement understated the true improvement in operational efficiency by roughly that margin.

Weeks 3 through 5 — Creative Scoring and first Money Wastage pass

Weeks 3 through 5 focused on creative. The Creative Scoring Matrix's Review zone contained 22 ads on intake — these had been running for anywhere from 8 to 45 days and were consuming 28 percent of daily spend against 12 percent of qualified leads. The kill sequence ran over 12 days rather than all at once because killing all 22 simultaneously would have destabilised delivery. The pattern was 3 to 4 kills per day, monitored 24 hours, next kill batch scheduled.

The Scalable zone had 12 ads. Budget got shifted from the killed Review ads to the Scalable ads at a 60/40 ratio (60 percent of freed budget to Scalable, 40 percent held as reserve for new creative variants). Scalable ads showed 15 to 25 percent CPL improvement over the two weeks following the reallocation.

The first Money Wastage Cleanup pass ran on day 32 and recovered ₹1.18L against the ₹1.42L initial estimate. The gap between estimate and actual recovered came from two ad sets whose waste had not been fully remediable through kill/scale actions because the client wanted to keep specific creative running for brand-continuity reasons (a physician-forward video the founder was personally attached to).

By end of week 5, CPL had dropped to ₹1,340. That reflected the compound of the Beacon attribution recovery, the creative kill sequence, and the Money Wastage recovery. The trajectory line on the Long-term Comparison view showed a clear inflection around day 25 and a stabilising downward slope through day 35.

Weeks 6 through 9 — CPQL Engine and competitive alignment

Weeks 6 through 9 shifted focus from CPL (raw cost per lead) to CPQL (cost per qualified lead). The CPQL Engine had accumulated enough qualified-lead data by day 42 to produce ad-set level CPQL scores. The gap between CPL and CPQL was material — some ad sets had CPL of ₹800 with CPQL of ₹3,200 (raw leads that did not qualify), while others had CPL of ₹1,600 with CPQL of ₹1,700 (nearly all leads qualifying).

The kill and scale decisions in weeks 6 through 9 got made on CPQL rather than CPL. Three ad sets that had looked like Scalable candidates on CPL turned out to be Review candidates on CPQL. Two ad sets that had looked like Getting Started candidates on CPL turned out to be Core Performer candidates on CPQL. The reallocation delivered a further 18 percent improvement in qualified-lead economics over the four-week window.

Competitive alignment ran in parallel. PrismSpy's IVF cluster showed that two Delhi competitors had launched EMI-framed offers in weeks 5 and 6 that were pulling share from the client's free-consultation framing. The client's creative team produced three new ad variants over weeks 7 and 8 that added EMI language to the existing free-consultation hook. The new variants entered Learning Phase in week 8 and exited in week 9, contributing to the CPL trajectory in weeks 10 through 12.

By end of week 9, CPL had dropped to ₹950. CPQL was ₹1,180, showing the gap between raw and qualified was narrowing as the account matured. Weekly qualified-lead volume had risen from 178 at intake to 411 without a proportional spend increase.

Weeks 10 through 12 — Compounding and cross-centre reallocation

Weeks 10 through 12 were compounding. Creative Scoring stabilised — the Core Performer zone grew from 8 to 17 ads, Scalable from 12 to 15, Getting Started shrunk from 19 to 9, and Review dropped from 22 to 4. Money Wastage recovery in month 3 was ₹68,000 (down from ₹1.18L in month 1 as the account matured and there was less accumulated waste to recover).

The cross-centre reallocation was the last major intervention. Master Dashboard showed the South Delhi centre operating at ₹680 CPQL and the Gurgaon centre at ₹1,020 CPQL — both inside the portfolio benchmark range but with material spread. The audit revealed that Gurgaon was targeting a broader geographic audience because the centre served both Gurgaon and outbound Delhi commuter catchments. Narrowing the Gurgaon audience to the actual catchment radius produced a 15 percent CPQL improvement on the Gurgaon centre in weeks 11 and 12.

By day 90, blended CPL was ₹732 and blended CPQL was ₹880. Weekly qualified-lead volume had risen to 517. The Money Wastage recovery over the 90 days totalled ₹2.94L against the initial ₹1.42L monthly estimate (the recovery was front-loaded because the initial waste concentration was in the pre-cleanup ads that got killed in weeks 3 through 5).

What did not improve as fast as expected

Honest limits matter. Three areas moved slower than the initial 90-day plan projected. First, video creative production capacity. The client's in-house video producer could not sustain the 4-to-6 new video variants per month that the ideal cycle would have required. Actual production was 2-to-3 per month, which means some Scalable ad sets did not receive fresh creative fast enough and drifted back toward Review by week 10. Fix in months 4 and 5 was to bring in a specialist ICG creative-partner for supplementary production.

Second, the physician-forward brand-continuity ads the founder wanted to keep running. Those ads had CPQL of ₹1,900 to ₹2,400 versus the account average of ₹880 by week 12. The founder's decision was to keep them because they served a brand-building function beyond pure lead economics. That is a legitimate call, but it kept the blended CPQL 8 to 12 percent above where it would otherwise have landed.

Third, the Gurgaon centre's narrower catchment produced better CPQL but lower total qualified-lead volume. The client and ICG together decided the trade-off was acceptable because the Gurgaon centre was capacity-constrained on consult slots anyway, but a growth-stage centre would have needed a different resolution.

What the honest 90-day outcome actually looks like

The headline number is ₹1,890 to ₹732 CPL, which is a 61 percent reduction and sits at the top end of the 38 to 58 percent portfolio benchmark reduction range. The more honest number is ₹1,890 CPL to ₹880 CPQL, because CPQL is what actually maps to the client's revenue funnel. That is a 53 percent reduction on the metric that matters.

Weekly qualified-lead volume rose from 178 to 517 — a 190 percent increase, achieved without proportional spend increase because the recovered Money Wastage and the improved creative efficiency were reinvested into scale rather than pulled out as savings. Total spend over the 90 days was ₹15.6L versus a projected ₹14.4L at intake spend rate — a 8 percent spend increase producing a 190 percent qualified-lead increase.

The client's intake conversion rate (qualified leads to first-consultation booking) also improved from 34 percent at intake to 42 percent by day 90, because the leads that came through the optimised funnel were better-matched to the clinic's actual catchment, capacity, and physician-specialisation profile. That intake conversion improvement was not a direct Meta Catalyst IQ contribution — it was a downstream effect of feeding a higher-quality qualified-lead pool into a clinic intake process that had always converted better on qualified leads than on raw ones.

What happened in months 4 through 6 after the 90-day intervention

Momentum held. By end of month 6, CPL had stabilised at ₹710 to ₹740 and CPQL at ₹820 to ₹880, both inside portfolio benchmark. Monthly qualified-lead volume settled at 2,100 to 2,400. Money Wastage per month had dropped to ₹35K to ₹50K from the initial ₹1.42L monthly rate, meaning the account was operating at roughly 7 percent of pre-optimisation waste — inside the 5 to 12 percent post-optimisation portfolio benchmark.

The daily rhythm from month 4 onward was the standard ICG two-tool loop — morning PrismSpy scan on the IVF cluster, midday Meta Catalyst IQ 2-Day Comparative review, afternoon creative brief for any changes needed. Total daily time investment on the account by month 4 was 35 to 55 minutes for the media buyer plus 15 to 20 minutes for the account lead.

Powered by Meta Catalyst IQ — the decision engine behind every Meta ad ICG runs

ICG built Meta Catalyst IQ because most Indian healthcare brands running Meta ads waste 30–50% of budget without knowing it. It's the diagnosis + decision layer above Ads Manager — Hygiene Factors 12-point checklist, Naming Intelligence (surfaces conflicts costing ₹50K–₹2L/account/month), Creative Scoring Matrix (Core Performer / Scalable / Getting Started / Review), 2-Day Comparative, SLC Framework, Money Wastage column in ₹. The IVF case study in this post is one of 11 IVF client accounts on the ICG portfolio, which collectively run ₹2.6Cr of monthly Meta spend at a ₹632 average CPL.

• Master Dashboard — 23+ accounts, ₹9.1Cr+ spend/mo optimised, ₹1,581 blended CPL vs ~₹3,200 market benchmark.
• Diagnose → Optimise → Grow — daily hygiene checks, weekly creative scoring, monthly money wastage cleanup.
• CPQL Engine — cost per qualified lead (not just cost per lead) at ad-set level. Try the interactive CPQL calculator.
• Portfolio benchmarks — IVF ₹632, derm ₹520–1,180, dental ₹620–1,800, aesthetic ₹400–900, hospital cardiac ₹3,200.

Included free with every ICG Meta ads or Performance Marketing engagement (Starter ₹20,000/-/month tier and above). Not sold standalone. Book a free 48-hour Meta ad diagnostic or WhatsApp us.

The case study above focused on the Meta Catalyst IQ (execution) layer. The competitive intelligence layer that runs alongside it is PrismSpy — tracking 30 to 45 IVF competitors daily so the creative briefs and offer positioning stay calibrated to market context. See the IVF combined-stack playbook for how the two layers work together on IVF specifically.

FAQ

Is this a real ICG client or a composite?

Real client, anonymised. The specific numbers (spend, CPL, timelines, ad-set counts) are unchanged from the actual case; only identifying details (clinic name, physician name, centre addresses) are removed. Client anonymisation is a standard ICG practice for case-study content.

Would this outcome be reproducible on a different IVF clinic?

Directionally yes, quantitatively with variance. The ICG IVF portfolio benchmark of ₹632 CPL is achievable on accounts that complete a similar 90-day intervention. Actual outcomes range from ₹560 to ₹950 CPL depending on city competitiveness, starting hygiene state, creative production capacity, and the founder's appetite for killing legacy ads with brand-attachment. The 38 to 58 percent CPL reduction range is the honest portfolio-wide result.

What if the starting CPL were much lower — say ₹1,100 already?

Reduction range compresses. An account already at ₹1,100 CPL typically has one or two of the five interventions already partially done. The 90-day outcome tends to land at ₹700 to ₹800 rather than the full portfolio benchmark, because the biggest levers (Money Wastage recovery and Creative Scoring kill sequence) have less headroom.

What about the intake conversion rate improvement — is that reproducible?

The intake conversion rate improvement is downstream and depends on the clinic's own intake process. Clinics with well-run intake (dedicated fertility counsellor, structured first-conversation script, same-day follow-up) see the improvement replicated. Clinics with weak intake see the raw qualified-lead improvement but not the conversion-rate improvement, because their intake becomes the bottleneck instead of their lead pool.

Does this work outside Delhi?

Yes. The ICG IVF portfolio spans Delhi NCR, Mumbai, Bengaluru, Hyderabad, Chennai, Pune, and Ahmedabad. The 90-day intervention framework is city-independent. Local competitive intensity varies (Mumbai is more expensive than Chennai) but the underlying diagnostic and remediation steps are identical.

What is the minimum monthly Meta ad spend for this intervention to make sense?

₹2L per month is the practical floor. Below that, Money Wastage recovery and Creative Scoring intervention have too little headroom to justify the operational overhead of the daily rhythm. The ideal sweet spot is ₹3.5L to ₹15L monthly spend where the interventions have enough surface area to compound meaningfully.

Can I get a Meta ad audit like the day-zero audit in this case study?

Yes. ICG runs a free 48-hour Meta ad diagnostic that produces exactly the day-zero picture — findability score, Hygiene Factors pass/fail, Creative Scoring distribution, Money Wastage estimate, portfolio benchmark comparison. Read-only Meta account access, no execution commitment. Book here.

Related reading

• Combined stack for IVF clinics — full playbook
• The Meta ads decision engine for Indian healthcare
• Ad set name drift detection
• Meta Catalyst IQ comparative alerts system
• Combined stack pillar — PrismSpy + Meta Catalyst IQ overview

Reference — National Medical Commission for physician promotion framing and Advertising Standards Council of India for advertising claim compliance.